The work of nine researchers who have previously received funding from Conquer Cancer is featured in ASCO’s Clinical Cancer Advances 2019. Visit CONQUER.ORG/CCA for more details.
Immunotherapy
At New York University Perlmutter Cancer Center in New York City, Leena Gandhi, MD, PhD, led a large clinical trial of patients with metastatic non–small cell lung cancer (NSCLC).
Leena Gandhi, MD, PhD, received a Conquer Cancer Young Investigator Award (YIA) in 2008.
The trial: Patients received either standard chemotherapy or chemotherapy plus pembrolizumab.
The results: Patients given immunotherapy in addition to chemotherapy lived significantly longer (and without tumor growth) than patients who received chemotherapy alone.
The impact: Lung cancer is the deadliest cancer for both men and women in the United States. Trials in NSCLC dramatically increase the patient population that can be considered for first-line treatment with immunotherapy. ■
© 2019. American Society of Clinical Oncology. All rights reserved.
